In one study, Cox et al. [70] found that the human CD34+CD19− and CD34+CD10− fractions derived from the bone marrow of B cell leukaemia patients aged 1–16 years old could engraft immunocompromised NOD/SCID mice and lead to the development of a leukaemia with a phenotype similar to patients. This evidence concerns the gene MME and leukemia.